SLU-PP-322
ERR agonist researched for exercise mimetic effects and mitochondrial biogenesis.
Testing & quality
Every batch is supplier-tested for identity and purity and randomly verified by independent third-party HPLC and mass spectrometry.
Compound classification
Small-molecule pan-Estrogen-Related Receptor (ERRα/β/γ) agonist.
Mechanism studied in the literature
Activates ERR transcription factors that govern mitochondrial biogenesis, fatty-acid oxidation, and oxidative phosphorylation gene programs. Studied in vitro and in rodent models as a putative exercise mimetic.
Research areas
- Mitochondrial biogenesis pathways
- Fatty-acid oxidation and skeletal muscle metabolism (preclinical)
- Exercise mimetic compound screening
- ERR receptor pharmacology
Storage
Lyophilized: -20°C, protected from light. Once in solution: 2-8°C, short-term storage only.
Reconstitution (laboratory)
Soluble in DMSO for in-vitro work. For sterile aqueous reconstitution use bacteriostatic water; concentration depends on the research protocol.
Related research peptides
Retatrutide
Triple agonist (GLP-1 / GIP / glucagon) studied for body composition and metabolic regulation research.
Tirzepatide
Dual GIP / GLP-1 receptor agonist studied for glycemic control and metabolic pathway research.
MOTS-c
Mitochondrial-derived peptide studied for insulin sensitivity, energy expenditure, and metabolic homeostasis.
AOD-9604
HGH fragment 176-191 studied for lipolytic and metabolic pathway research.